Specifically, MPO activity and ROS production were negatively correlated with β-hydroxybutyrate levels, implying that β-hydroxybutyrate may reduce oxidative stress, which is often increased in colitis and contributes to gut inflammation. The gene discussed is MPO; the disease is colitis.